GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » E10

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) E10 : ¥0.29 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Ausun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.29 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-12-13), Zhejiang Ausun Pharmaceutical Co's current stock price is ¥8.75. Zhejiang Ausun Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥0.29. Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio of today is 30.17.

During the past 12 years, the highest Shiller PE Ratio of Zhejiang Ausun Pharmaceutical Co was 31.17. The lowest was 27.62. And the median was 28.83.


Zhejiang Ausun Pharmaceutical Co E10 Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co E10 Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.29

Competitive Comparison of Zhejiang Ausun Pharmaceutical Co's E10

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio falls into.



Zhejiang Ausun Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhejiang Ausun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.06/115.7848*115.7848
=0.060

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Ausun Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201212 -0.260 95.237 -0.316
201312 0.350 97.624 0.415
201412 0.450 99.000 0.526
201503 0.046 99.900 0.053
201512 0.560 100.600 0.645
201603 0.022 102.200 0.025
201606 0.015 101.400 0.017
201609 0.024 102.400 0.027
201612 0.043 102.600 0.049
201703 0.022 103.200 0.025
201706 0.020 103.100 0.022
201709 0.009 104.100 0.010
201712 0.030 104.500 0.033
201803 0.002 105.300 0.002
201806 0.029 104.900 0.032
201809 0.011 106.600 0.012
201812 0.015 106.500 0.016
201903 0.011 107.700 0.012
201906 0.032 107.700 0.034
201909 0.027 109.800 0.028
201912 0.009 111.200 0.009
202003 0.027 112.300 0.028
202006 0.033 110.400 0.035
202009 0.018 111.700 0.019
202012 0.029 111.500 0.030
202103 0.055 112.662 0.057
202106 0.052 111.769 0.054
202109 0.031 112.215 0.032
202112 0.046 113.108 0.047
202203 0.092 114.335 0.093
202206 0.066 114.558 0.067
202209 0.069 115.339 0.069
202212 0.071 115.116 0.071
202303 0.114 115.116 0.115
202306 0.080 114.558 0.081
202309 0.078 115.339 0.078
202312 0.037 114.781 0.037
202403 0.136 115.227 0.137
202406 0.084 114.781 0.085
202409 0.060 115.785 0.060

Add all the adjusted EPS together and divide 10 will get our e10.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Ausun Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.75/0.29
=30.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Shiller P/E Ratio of Zhejiang Ausun Pharmaceutical Co was 31.17. The lowest was 27.62. And the median was 28.83.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Zhejiang Ausun Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Executives
Zheng Zhi Guo Directors, senior managers
Zhang Hua Dong Directors, senior managers
Liu Bing Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines